Lack of effectiveness of routine clinic and blood test-based follow-up for diffuse large B cell lymphoma

Br J Haematol. 2018 Jul;182(1):138-140. doi: 10.1111/bjh.14745. Epub 2017 May 9.

Authors

Beth Chasty¹, Michael Patterson¹, Louise J Murray², Rod Johnson³, Emma Thomas², Di Gilson², Cathy Burton³, Robin J D Prestwich²

Affiliations

¹ University of Leeds School of Medicine, Leeds, UK.
² Department of Clinical Oncology, Leeds Cancer Centre, Leeds, UK.
³ Department of Haematology, Leeds Cancer Centre, Leeds, UK.

PMID: 28485468
DOI: 10.1111/bjh.14745

No abstract available

Keywords: chemotherapy; diffuse large B cell lymphoma; follow-up; lactate dehydrogenase; relapse detection.

MeSH terms

Adult
Aged
Aged, 80 and over
Female
Follow-Up Studies
Hematologic Tests
Humans
Long-Term Care / methods
Long-Term Care / standards*
Lymphoma, Large B-Cell, Diffuse / diagnosis*
Lymphoma, Large B-Cell, Diffuse / therapy
Male
Middle Aged
Population Surveillance / methods
Recurrence
Remission Induction
Young Adult